Clinical Trials at USC

1 Results for

Study Title	Principal Investigator
Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Phase III Study to Investigate the Efficacy, Safety, and Tolerability of 2 Different Doses of IgPro20 (Subcutaneous Immunoglobulin) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - the PATH Study Active, not recruiting \| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) \| Multisite View full trial information >>	Prof. Schaik

Study Title

Principal Investigator

Active, not recruiting | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Multisite

Prof. Schaik